1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
2
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar
|
3
|
Grünwald D, Singer RH and Rout M: Nuclear
export dynamics of RNA-protein complexes. Nature. 475:333–341.
2011.PubMed/NCBI
|
4
|
Siddiqui N and Borden KL: mRNA export and
cancer. Wiley Interdiscip Rev RNA. 3:13–25. 2012. View Article : Google Scholar
|
5
|
Chow KH, Factor RE and Ullman KS: The
nuclear envelope environment and its cancer connections. Nat Rev
Cancer. 12:196–209. 2012.PubMed/NCBI
|
6
|
Yang J, Bogerd HP, Wang PJ, Page DC and
Cullen BR: Two closely related human nuclear export factors utilize
entirely distinct export pathways. Mol Cell. 8:397–406. 2001.
View Article : Google Scholar
|
7
|
van der Watt PJ and Leaner VD: The nuclear
exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and
repressed by p53 in response to DNA damage. Biochim Biophys Acta.
1809:316–326. 2011.PubMed/NCBI
|
8
|
Yin Y, Wang G, Liang N, et al: Nuclear
export factor 3 is involved in regulating the expression of
TGF-beta3 in an mRNA export activity-independent manner in mouse
Sertoli cells. Biochem J. 452:67–78. 2013.PubMed/NCBI
|
9
|
Petrella BL, Armstrong DA and Vincenti MP:
Interleukin-1 beta and transforming growth factor-beta 3 cooperate
to activate matrix metalloproteinase expression and invasiveness in
A549 lung adenocarcinoma cells. Cancer Lett. 325:220–226. 2012.
View Article : Google Scholar
|
10
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: a study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ke AW, Shi GM, Zhou J, et al: Role of
overexpression of CD151 and/or c-Met in predicting prognosis of
hepatocellular carcinoma. Hepatology. 49:491–503. 2009. View Article : Google Scholar
|
13
|
Cullen BR: Nuclear mRNA export: insights
from virology. Trends Biochem Sci. 28:419–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shen A, Wang Y, Zhao Y, Zou L, Sun L and
Cheng C: Expression of CRM1 in human gliomas and its significance
in p27 expression and clinical prognosis. Neurosurgery. 65:153–160.
2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
van der Watt PJ, Maske CP, Hendricks DT,
et al: The Karyopherin proteins, Crm1 and Karyopherin beta1, are
overexpressed in cervical cancer and are critical for cancer cell
survival and proliferation. Int J Cancer. 124:1829–1840. 2009.
|
16
|
Inoue H, Kauffman M, Shacham S, et al:
CRM1 blockade by selective inhibitors of nuclear export attenuates
kidney cancer growth. J Urol. 189:2317–2326. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lyon MF: Gene action in the X-chromosome
of the mouse (Mus musculus L.). Nature. 190:372–373. 1961.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Lyon MF: Sex chromatin and gene action in
the mammalian X-chromosome. Am J Hum Genet. 14:135–148.
1962.PubMed/NCBI
|
19
|
Spatz A, Borg C and Feunteun J:
X-chromosome genetics and human cancer. Nat Rev Cancer. 4:617–629.
2004. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Chen JG and Zhang SW: Liver cancer
epidemic in China: past, present and future. Semin Cancer Biol.
21:59–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang N, Zheng Y, Yu X, Lin W, Chen Y and
Jiang Q: Sex-modified effect of hepatitis B virus infection on
mortality from primary liver cancer. Am J Epidemiol. 169:990–995.
2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kau TR, Way JC and Silver PA: Nuclear
transport and cancer: from mechanism to intervention. Nat Rev
Cancer. 4:106–117. 2004. View
Article : Google Scholar : PubMed/NCBI
|
24
|
van der Horst A and Burgering BM:
Stressing the role of FoxO proteins in lifespan and disease. Nat
Rev Mol Cell Biol. 8:440–450. 2007.PubMed/NCBI
|
25
|
Kau TR, Schroeder F, Ramaswamy S, et al: A
chemical genetic screen identifies inhibitors of regulated nuclear
export of a Forkhead transcription factor in PTEN-deficient tumor
cells. Cancer Cell. 4:463–476. 2003. View Article : Google Scholar
|
26
|
Sakakibara K, Saito N, Sato T, et al:
CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1
degrading activity. Blood. 118:3922–3931. 2011. View Article : Google Scholar : PubMed/NCBI
|
27
|
Mao L and Yang Y: Targeting the nuclear
transport machinery by rational drug design. Curr Pharm Des.
19:2318–2325. 2013. View Article : Google Scholar : PubMed/NCBI
|